Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Infertility, Female Infertility, Male Infertility AND Infertility

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44343   clinical trials with a EudraCT protocol, of which   7372   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    83 result(s) found for: Infertility, Female Infertility, Male Infertility AND Infertility. Displaying page 1 of 5.
    1  2  3  4  5  Next»
    EudraCT Number: 2021-000941-42 Sponsor Protocol Number: FSD-IEQ-2021-03 Start Date*: 2021-07-06
    Sponsor Name:Fundacion Santiago Dexeus Font
    Full Title: The impact of the intensity of ovarian stimulation on embryo quality in predicted suboptimal responders. A randomized controlled trial.
    Medical condition: To compare the number of GQB and the morphokinetic parameters of early embryo development in infertile suboptimal patients undergoing two different intensities of ovarian stimulation, a milder appr...
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10021928 Infertility female PT
    21.0 10038604 - Reproductive system and breast disorders 10021926 Infertility PT
    20.0 10038604 - Reproductive system and breast disorders 10021930 Infertility NOS LLT
    20.0 10038604 - Reproductive system and breast disorders 10021929 Infertility male PT
    20.1 10038604 - Reproductive system and breast disorders 10016399 Female infertility (primary) LLT
    21.1 10038604 - Reproductive system and breast disorders 10039843 Secondary infertility (female) LLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2021-004254-37 Sponsor Protocol Number: 000400 Start Date*: 2022-06-27
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: A randomised, double-blind, placebo-controlled trial to assess the efficacy and safety of FE 999049 for treatment of men with idiopathic infertility
    Medical condition: Idiopathic male infertility (including oligoasthenozoospermia)
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10021929 Infertility male PT
    Population Age: Adults Gender: Male
    Trial protocol: SE (Trial now transitioned) DE (Trial now transitioned) ES (Trial now transitioned) DK (Trial now transitioned) BE (Trial now transitioned) IT (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2017-002936-17 Sponsor Protocol Number: LIV001 Start Date*: 2019-02-22
    Sponsor Name:Livio Falun
    Full Title: Treatment with intralipid in assisted fertilization
    Medical condition: Infertility conditions that required IVF treatment Male infertility Endometrosis PCOS uNEXPLAINED INFERTILITY Tubal damage
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-003810-13 Sponsor Protocol Number: 000289 Start Date*: 2018-05-21
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: A randomised, double-blind, placebo-controlled, parallel-group, dose-range trial to investigate the efficacy and safety of FE 999302 as add-on treatment to follitropin delta (REKOVELLE) in women un...
    Medical condition: Women diagnosed with tubal infertility or unexplained infertility or endometriosis stage I/II or having partners diagnosed with male factor infertility, eligible for IVF and/or ICSI.
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004872 10021940 Infertility, female, of unspecified origin LLT
    21.0 100000004872 10016403 Female infertility of tubal origin LLT
    21.1 100000004872 10025511 Male infertility, unspecified LLT
    21.0 100000004872 10014787 Endometriosis of uterus LLT
    21.0 100000004872 10014784 Endometriosis of ovary LLT
    Population Age: Adults Gender: Female
    Trial protocol: CZ (Completed) DK (Completed) BE (Completed) GB (GB - no longer in EU/EEA) ES (Completed)
    Trial results: View results
    EudraCT Number: 2015-005682-24 Sponsor Protocol Number: RIOTA2015 Start Date*: 2016-03-16
    Sponsor Name:Sven Olaf Skouby, Professor, MD, DMSc. Unit of Reproductive Medicine, Herlev/Gentofte Hospital
    Full Title: REDUCING THE IMPACT OF OVARIAN STIMULATION - THE RIOT PROJECT STUDY RIOT A: THE ROLE OF AROMATASE INHIBITOR IN REDUCING THE DETRIMENTAL EFFECTS OF OVARIAN STIMULATION TO OPTIMIZE OUTCOMES IN FRESH...
    Medical condition: Infertility
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004872 10016401 Female infertility of other specified origin LLT
    20.0 100000004872 10025511 Male infertility, unspecified LLT
    20.0 100000004872 10016403 Female infertility of tubal origin LLT
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-005683-41 Sponsor Protocol Number: RIOTB2015 Start Date*: 2016-03-16
    Sponsor Name:Sven O. Skouby, Professor, MD, DMSc. Unit of reproductive Medicine, Herlev/Gentofte Hospital
    Full Title: REDUCING THE IMPACT OF OVARIAN STIMULATION - THE RIOT PROJECT RIOT STUDY B: MAPPING THE ENDOCRINE DETERMINANTS OF OVARIAN STIMULATION TO OPTIMIZE OUTCOMES IN FRESH EMBRYO TRANSFER CYCLES ...
    Medical condition: Infertility
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004872 10016401 Female infertility of other specified origin LLT
    20.0 100000004872 10025511 Male infertility, unspecified LLT
    20.0 100000004872 10016403 Female infertility of tubal origin LLT
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-023534-23 Sponsor Protocol Number: EMR 200061-504 Start Date*: 2011-05-09
    Sponsor Name:Merck Serono S.A. - Geneva
    Full Title: A phase IIIB, multicentre, multinational, randomized, open-label trial to compare the efficacy and safety of ovarian stimulation with GONAL-f® day 1 to day 5 followed by Pergoveris® starting day 6 ...
    Medical condition: Fertility disorders
    Disease: Version SOC Term Classification Code Term Level
    12.1 10016398 Female infertility LLT
    12.1 10016399 Female infertility (primary) LLT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Completed) SK (Completed) DE (Completed) FI (Completed) GB (Completed) DK (Completed) GR (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2010-020240-35 Sponsor Protocol Number: 2010-020240-35 Start Date*: 2010-07-09
    Sponsor Name:AZIENDA OSPEDALIERA POLICLINICO DI MODENA
    Full Title: Significance of the FSH receptor polymorphism p.N680S for the efficacy of FSH therapy of idiopathic male infertility: a pharmacogenetic approach.
    Medical condition: Idiopathic male infertility
    Disease: Version SOC Term Classification Code Term Level
    9.1 10014701 HLGT
    9.1 10021011 LLT
    Population Age: Adults Gender: Male
    Trial protocol: IT (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2016-005145-23 Sponsor Protocol Number: 53736 Start Date*: 2017-08-29
    Sponsor Name:DIPARTIMENTO DI SCIENZE CHIRURGICHE - UNIVERSITà DEGLI STUDI DI TORINO
    Full Title: Prospective randomized trial comparing corifollitropin alfa (CF-alfa) late start (day 4) vs. CF-alfa standard start (day2) in poor, normal and potential high-responders undergoing IVF/ICSI
    Medical condition: Women with low reproductive capacity
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004860 10002658 Anovulation LLT
    20.1 100000004872 10016398 Female infertility LLT
    20.0 100000004865 10071102 Controlled ovarian hyperstimulation LLT
    Population Age: Adults Gender: Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2022-000753-80 Sponsor Protocol Number: 000298 Start Date*: 2022-08-04
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: A randomised, assessor-blind, active-controlled, parallel-group, dose-finding trial to investigate the efficacy and safety of FE 999302 for triggering of final follicular maturation in women underg...
    Medical condition: Infertility
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004872 10016398 Female infertility LLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Prematurely Ended) CZ (Prematurely Ended) DK (Completed)
    Trial results: View results
    EudraCT Number: 2021-001785-38 Sponsor Protocol Number: 000401 Start Date*: 2021-10-05
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: A randomised, controlled, assessor-blind, parallel groups, multicentre, multinational trial comparing the ovarian response of a starting dose of 15 µg follitropin delta (REKOVELLE) to a starting do...
    Medical condition: Infertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10021928 Infertility female PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing) IT (Completed) FR (Completed) AT (Completed)
    Trial results: View results
    EudraCT Number: 2017-002783-40 Sponsor Protocol Number: 000304 Start Date*: 2019-07-04
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: A randomised, controlled, open label, parallel group, multicentre trial comparing the efficacy and safety of individualised FE 999049 (follitropin delta) dosing, using a long GnRH agonist protocol ...
    Medical condition: Infertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004872 10016398 Female infertility LLT
    21.0 100000004872 10016403 Female infertility of tubal origin LLT
    21.1 100000004872 10025511 Male infertility, unspecified LLT
    21.0 100000004872 10014787 Endometriosis of uterus LLT
    21.0 100000004872 10014784 Endometriosis of ovary LLT
    Population Age: Adults Gender: Female
    Trial protocol: AT (Completed) DK (Completed) NO (Completed) NL (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2016-001950-16 Sponsor Protocol Number: ISI-2015-1 Start Date*: 2017-03-03
    Sponsor Name:Isifer AB
    Full Title: A randomized, double blind, controlled, parallel group, multi-centre phase II clinical study of lidocaine pertubation as a treatment for couples with unexplained infertility
    Medical condition: Unexplained infertility
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: PL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-003788-67 Sponsor Protocol Number: FS1306 Start Date*: 2014-01-29
    Sponsor Name:Watson Laboratories, Inc. - A subsidiary of Actavis, Inc.
    Full Title: A Randomised, Parallel Group, Assessor-Blind, Multicentre Study to Compare the Safety and Efficacy of Watson rhFSH with Follitropin Alfa (GONAL-f) in Stimulating Multiple Follicular Development in ...
    Medical condition: Stimulation of multifollicular development in women undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer and...
    Disease: Version SOC Term Classification Code Term Level
    17.0 10038604 - Reproductive system and breast disorders 10021928 Infertility female PT
    Population Age: Adults Gender: Female
    Trial protocol: BE (Completed) GB (Prematurely Ended) ES (Prematurely Ended) AT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2018-001137-41 Sponsor Protocol Number: 666 Start Date*: 2018-06-26
    Sponsor Name:Hvidovre Hospital. Dep of Respiratory Medicine
    Full Title: Use of Omalizumab will increase the pregnancy rate, proof of concept study, where women with asthma and infertility will be treated three times with weight and IgE balanced dosis at the sixth day o...
    Medical condition: infertility within female asthma patients as a result of systemic inflamation.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-000633-36 Sponsor Protocol Number: 000009 Start Date*: 2011-08-09
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: A randomised, controlled, assessor-blind, parallel groups, multinational, multicentre trial assessing the dose-response relationship of FE 999049 in controlled ovarian stimulation in women undergoi...
    Medical condition: Infertility
    Disease: Version SOC Term Classification Code Term Level
    14.0 10038604 - Reproductive system and breast disorders 10021926 Infertility PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed) BE (Completed) CZ (Completed) DK (Completed)
    Trial results: View results
    EudraCT Number: 2013-001034-18 Sponsor Protocol Number: NL43131-018-13 Start Date*: 2013-09-05
    Sponsor Name:AMC Amsterdam
    Full Title: Super ovulation in intrauterine insemination: FSH or Clomifene citrate
    Medical condition: Women diagnosed with unexplained subfertility or mild male factor subfertility with an indication for intra uterine insemination
    Disease: Version SOC Term Classification Code Term Level
    14.1 10038604 - Reproductive system and breast disorders 10021926 Infertility PT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-001259-22 Sponsor Protocol Number: 28613 Start Date*: 2008-09-01
    Sponsor Name:Merck Serono International S.A.
    Full Title: A phase IV prospective, multicentre, randomized, open-label trial to assess the efficacy and safety of GONAL f® at a dose based on subject baseline characteristics determined according to the CONSO...
    Medical condition: Ovarian stimulation in women undergoing assisted reproductive technology
    Disease: Version SOC Term Classification Code Term Level
    9.1 10021930 Infertility NOS LLT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Completed) SE (Completed) ES (Completed) DE (Completed) DK (Completed) GB (Completed) IT (Completed) FR (Completed)
    Trial results: View results
    EudraCT Number: 2013-001669-17 Sponsor Protocol Number: 000004 Start Date*: 2013-09-17
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: A randomised, controlled, assessor-blind, parallel groups, multicentre, multinational trial comparing the efficacy and safety of FE 999049 with follitropin alfa (GONAL-F) in controlled ovarian stim...
    Medical condition: Infertility
    Disease: Version SOC Term Classification Code Term Level
    16.0 10038604 - Reproductive system and breast disorders 10021926 Infertility PT
    Population Age: Adults Gender: Female
    Trial protocol: BE (Completed) GB (Completed) CZ (Completed) DK (Completed) PL (Completed) ES (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2016-001590-32 Sponsor Protocol Number: MMC-2016-01 Start Date*: 2018-04-19
    Sponsor Name:Manuel Macía Cortiñas
    Full Title: Comparison of two protocols of controlled ovarian stimulation with highly purified menotropin in low-responder patients according to Bologna criteria treated in Spanish public hospitals.
    Medical condition: PRIMARY INFERTILITY
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004872 10016399 Female infertility (primary) LLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun Jun 15 13:49:19 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA